99mTc-P748

N/A

Report date: 2025/11/24 17:58:20

NME

Base Information

Drug Name99mTc-P748

Drug Alias Name[99mTc]-P748P748-[99mTc]99mTc-P748

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTcSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[5]

Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists

TargetsIntegrin alpha-IIb/beta-3

Therapy Area/IndicationsThrombosisPulmonary Embolism

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsThrombosisPulmonary Embolism

Other Information

ATC CodeN/A